Yersinia Pestis

The causative agent of plague — one of the most devastating infectious diseases in human history and a modern bioterrorism concern (Tier 1 Select Agent). Y. pestis depends on nickel for glyoxalase I-mediated metabolic detoxification and produces the archetypal dual-function metallophore yersiniabactin, which chelates both iron and nickel.

Nickel-Dependent Virulence

Ni-Glyoxalase I (GloI)

  • Y. pestis possesses a confirmed Ni-dependent glyoxalase that detoxifies methylglyoxal, the reactive and mutagenic byproduct of glycolysis [1].
  • During explosive growth in the host bloodstream (bacteremia can reach >10^8 CFU/mL in septicemic plague), high glycolytic flux generates toxic methylglyoxal concentrations.
  • Without Ni-GloI, the pathogen's own metabolism becomes self-poisoning — nickel availability is thus essential for sustained bacteremic growth.
  • Human GloI uses zinc, not nickel. This metal selectivity difference creates a potential target for selective inhibitors that would not affect host GloI.

Iron and Multi-Metal Acquisition

Yersiniabactin (Ybt)

  • Y. pestis produces yersiniabactin, the founding member of this siderophore/metallophore family [2].
  • Ybt binds Fe3+ with high affinity for classical iron acquisition during infection.
  • Also chelates extracellular nickel and copper — a true multi-metal metallophore [1].
  • The Ybt biosynthesis locus resides on the High Pathogenicity Island (HPI), which has been horizontally transferred to klebsiella pneumoniae, UPEC escherichia coli, and other Enterobacteriaceae — spreading multi-metal acquisition capability across pathogen families.
  • Cu-Ybt complexes may help Y. pestis resist copper toxicity encountered in macrophage phagosomes.

Other Iron Systems

  • Yersiniabactin is the primary siderophore; Y. pestis also acquires heme via the Hmu system.
  • Iron acquisition is tightly regulated by Fur (ferric uptake regulator).

Pathogenesis and Metal Context

  • Flea transmission: Y. pestis forms a biofilm in the flea proventriculus, blocking blood feeding and forcing the flea to regurgitate bacteria during subsequent bites. Iron availability in the flea blood meal likely supports biofilm formation.
  • Bubonic plague: bacteria multiply in regional lymph nodes (buboes). Metal acquisition from lysed host cells provides iron and other metals.
  • Septicemic plague: massive bloodstream infection. The Ni-GloI dependency is most critical during this phase due to the high metabolic rate.
  • Pneumonic plague: person-to-person airborne transmission. The most lethal form (near 100% mortality if untreated).

Clinical Significance

  • Plague: untreated bubonic plague has 60-90% mortality; septicemic and pneumonic forms approach 100%.
  • Approximately 1,000-2,000 cases reported annually to WHO, with foci in Africa, Asia, and the Americas.
  • Bioterrorism: classified as a CDC Category A bioterrorism agent. Aerosolized Y. pestis could cause pneumonic plague outbreaks.
  • Treatment requires rapid administration of aminoglycosides (streptomycin, gentamicin) or doxycycline.
  • Multidrug-resistant strains have been documented in Madagascar.

Connections

  • glyoxalase — Ni-GloI for methylglyoxal detoxification during bacteremia
  • siderophores metallophores — yersiniabactin as the archetypal dual Fe/Ni/Cu metallophore
  • nickel — cofactor for GloI; also acquired via yersiniabactin
  • iron — primary siderophore target; essential for growth in host
  • copper — Ybt-Cu complexes resist macrophage copper toxicity
  • metal dependent virulence — GloI and yersiniabactin as complementary metal-virulence systems
  • klebsiella pneumoniae — acquired yersiniabactin HPI via horizontal transfer
  • escherichia coli — UPEC strains carry yersiniabactin for Fe/Ni/Cu acquisition
  • nutritional immunity — host iron/nickel restriction as defense against plague

References (8)

  1. Robert J. Maier, Stéphane L. Benoit (2019). Role of Nickel in Microbial Pathogenesis. Inorganics. doi:10.3390/inorganics7070080
  2. Patil RH, Luptakova D, Havlicek V (2021). Infection metallomics for critical care in the post-COVID era. Mass Spectrometry Reviews. doi:10.1002/mas.21755
  3. Patil, A., Gholap et al. (2021). Patil 2021 — Infection Metallomics in the COVID Era. Mass Spectrometry Reviews. doi:10.1002/mas.21755
  4. Docimo G, Cangiano A, Romano RM et al. (2020). Docimo et al. 2020 — The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases. Frontiers in Endocrinology. doi:10.3389/fendo.2020.586529
  5. Antonelli A, Ferrari SM, Ragusa F et al. (2023). Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Practice & Research Clinical Endocrinology & Metabolism. doi:10.1016/j.beem.2023.101800
  6. Prabavathi Devarajalu, Savita Verma Attri, Jogender Kumar et al. (2025). Devarajalu 2025 — Gut microbiota signatures in Indian preterm infants with NEC: shotgun metagenomic approach. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2025.1649384
  7. Sara Vascellari, Marta Melis, Alessandra Ferraris (2022). Vascellari 2022 -- Gut Microbiome Biomarkers in Parkinson's Disease via Shotgun Metagenomics. npj Biofilms and Microbiomes. doi:10.1038/s41522-022-00367-z
  8. Su X, Yin X, Liu Y et al. (2020). Su et al. 2020 — Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid. The Journal of Clinical Endocrinology & Metabolism. doi:10.1210/clinem/dgaa511